The brain α7 nicotinic receptor may be an important therapeutic target for the treatment of Alzheimer's disease: studies with DMXBA (GTS-21)

This publication has 51 references indexed in Scilit:

• Metabolism and disposition of GTS-21, a novel drug for Alzheimer's disease
  Xenobiotica, 1999
• Nicotinic α7 receptors protect against glutamate neurotoxicity and neuronal ischemic damage
  Published by Elsevier ,1998
• Nicotinic receptor stimulation protects neurons against β‐amyloid toxicity
  Annals of Neurology, 1997
• Hippocampal synaptic transmission enhanced by low concentrations of nicotine
  Nature, 1996
• An evaluation of neuronal nicotinic acetylcholine receptor activation by quaternary nitrogen compounds indicates that choline is selective for the α7 subtype
  Neuroscience Letters, 1996
• Calcium-mediated Gene Expression: Mechanism for Neuronal Plasticity and Survival
  The Neuroscientist, 1995
• Evaluation of Cognition‐enhancing Drugs: Utility of the Model System of Eyeblink Classical Conditioning
  CNS Drug Reviews, 1995
• Diversity of neuronal nicotinic acetylcholine receptors: Lessons from behavior and implications for cns therapeutics
  Life Sciences, 1995
• Calcium influx through nicotinic receptor in rat central neurons: Its relevance to cellular regulation
  Neuron, 1992
• Reduced number of [3H]nicotine and [3H]acetylcholine binding sites in the frontal cortex of Alzheimer brains
  Neuroscience Letters, 1986